FDA May Allow Fewer Mentions Of Generic Name In Drug Ads

Draft guidance outlines when agency will use enforcement discretion.

FDA has relaxed its advice on when, where and how often companies need to include the generic name of a product in advertising and promotional labeling in a Nov. 18 draft guidance.

For instance, the draft says FDA intends to exercise enforcement discretion if the generic name of a drug,...

More from United States

More from North America